Inventor

BRUENKER PETER

CH36 patents

⚠️ This page may combine multiple inventors who share the name “BRUENKER PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRUENKER PETER

HOFFMANN LA ROCHE

Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer

Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer

Bispecific antibodies specific for OX40

Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules

Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

Multispecific domain exchanged common variable light chain antibodies

Bispecific antigen binding molecules comprising anti-FAP clone 212

Antibody fab and Fc variants

Trimeric antigen binding molecules

Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

Bispecific antibodies specific for OX40

Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof

T cell activating bispecific antigen binding molecules

T cell activating bispecific antigen binding molecules

Protease-activated T cell bispecific molecules

Bispecific antigen binding molecules comprising anti-FAP clone 212

Bispecific antigen binding molecules capable of specific binding to CD40 and to fap

ROCHE GLYCART AG

Mutant interleukin-2 polypeptides

Immunoconjugates

Mutant interleukin-2 polypeptides

Immunoconjugates

Immunoconjugates

Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5

Mutant interleukin-2 polypeptides

Antibodies specific for DR5 and methods of use

Fc-free antibodies comprising two fab-fragments and methods of use

Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function

Bispecific T cell activating antigen binding molecules

Bispecific antibodies specific for T-cell activating antigens and a tumor antigen and methods of use

Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function

AST OLIVER

Immunoconjugates

Mutant interleukin-2 polypeptides

BRINKMANN ULRICH

Multispecific antibodies comprising full length antibodies and single chain fab fragments

BRUENKER PETER

DR5—FAP bispecific death receptor agonistic antibodies

HOFFMANN—LA ROCHE INC

Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety

SOLIDAGO AG

Methods and compositions for increasing production of erythromycin